Anavex Life Sciences Corp (AVXL)

[Anshu2]

Thanks for some of the info. Two comments.

1. I doubt FDA would accept brain volume as a surrogate marker (I gave my readings in an earlier list). But it may.

2. Biggest issue I see is dosage arm data. Since CM hasn’t released it, I’m inclined to think that dose-level data is not statistically significant and/or has other issues. FDA will certainly not approve based on pooled data — that’s guaranteed.